Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Renal cell carcinoma: Which Medications Are Safest? (209 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

209 medications are used for Renal cell carcinoma, with 31,459 combined adverse event reports. The most reported drugs for Renal cell carcinoma are CABOZANTINIB S-MALATE and NIVOLUMAB.

31,459
Total Reports
209
Drugs Used

All Medications for Renal cell carcinoma Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
CABOZANTINIB S-MALATE CABOMETYX 9,156 4,203 6,193 10.7%
NIVOLUMAB OPDIVO 6,514 23,086 36,530 26.3%
LENVATINIB Lenvima 3,849 4,449 19,975 13.2%
PEMBROLIZUMAB KEYTRUDA 3,027 15,543 35,472 18.6%
SUNITINIB MALATE Sunitinib malate 2,926 6,028 5,720 27.9%
PAZOPANIB Pazopanib 2,799 5,612 4,347 26.5%
IPILIMUMAB YERVOY 2,585 8,043 17,031 22.0%
AXITINIB INLYTA 2,447 3,141 4,050 19.8%
EVEROLIMUS EVEROLIMUS 1,573 8,374 11,211 21.1%
TIVOZANIB FOTIVDA 1,258 135 291 9.7%
CABOZANTINIB - 1,241 767 2,771 20.0%
SORAFENIB sorafenib 454 2,489 3,547 22.8%
BEVACIZUMAB JOBEVNE 365 17,498 23,114 22.4%
AVELUMAB BAVENCIO 316 861 1,630 23.7%
ATEZOLIZUMAB Tecentriq Hybreza 312 8,520 15,094 25.3%
BELZUTIFAN WELIREG 291 82 550 8.0%
SUTENT - 247 386 259 32.2%
TEMSIROLIMUS Temsirolimus 213 361 727 21.9%
SUNITINIB - 143 306 430 17.2%
UNSPECIFIED INGREDIENT - 134 6,132 11,236 23.4%

View all 209 drugs →

Most Reported Drugs for Renal cell carcinoma

#1 most reported
#2 most reported
#3 most reported